Results 261 to 270 of about 484,117 (322)

A Phase 1 Open‐Label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Intranasal Dose of Zavegepant in Healthy Chinese Adults

open access: yesClinical Pharmacology in Drug Development, EarlyView.
Abstract Zavegepant is the only calcitonin gene‐related peptide antagonist approved as a nasal spray in the United States for acute treatment of migraine in adults with or without aura. This Phase 1, open‐label study evaluated the pharmacokinetics, safety, and tolerability of a single intranasal dose of zavegepant 10 mg in 12 healthy Chinese adults ...
Qiong Wei   +11 more
wiley   +1 more source

Reduced lung function among non-smoking workers in the paper industry in Ethiopia: a comparative cross-sectional study. [PDF]

open access: yesInt Arch Occup Environ Health
Tafese A   +6 more
europepmc   +1 more source

Parasympathetic response in women with coronary vascular dysfunction during mental stress compared to those with non-cardiac chest pain and reference controls. [PDF]

open access: yesInt J Cardiol Heart Vasc
Mehta PK   +17 more
europepmc   +1 more source

Stimulants for disorders of consciousness in the intensive care unit: a randomized, placebo-controlled trial. [PDF]

open access: yesBrain
Othman MH   +29 more
europepmc   +1 more source

Decade effects in mental addition. [PDF]

open access: yesPhilos Trans R Soc Lond B Biol Sci
Neth H, Payne SJ.
europepmc   +1 more source

Home - About - Disclaimer - Privacy